HIV drug stabilizes progression in metastatic colorectal cancer

A drug widely used in HIV therapy has shown to stop disease progression in 25 percent of patients with fourth-line metastatic colorectal cancer.

Alice McCarthy • harvard
April 4, 2022 ~5 min

Coffee linked to improved survival in metastatic colorectal cancer

Data from a large observational study suggests coffee consumption is associated with a lower risk of metastatic colorectal cancer progression and death.

Rob Levy • harvard
Sept. 17, 2020 ~4 min


High-dose vitamin D shows benefit in patients with advanced colorectal cancer

The first randomized clinical trial of vitamin D in patients with metastatic colorectal cancer found that high doses of supplements combined with chemotherapy delayed disease progression.

Richard Saltus • harvard
April 9, 2019 ~6 min

/

1